c-Src kinase inhibition reduces arrhythmia inducibility and connexin43 dysregulation after myocardial infarction.

[1]  R. Solaro,et al.  Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties. , 2013, Journal of molecular and cellular cardiology.

[2]  Fu Siong Ng,et al.  Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes. , 2012, American journal of physiology. Heart and circulatory physiology.

[3]  D. Rosenbaum,et al.  Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction. , 2012, Journal of the American College of Cardiology.

[4]  I. Cohen,et al.  Suppression of Phosphoinositide 3-Kinase Signaling and Alteration of Multiple Ion Currents in Drug-Induced Long QT Syndrome , 2012, Science Translational Medicine.

[5]  M. Bonini,et al.  Inhibition of c-Src tyrosine kinase prevents angiotensin II-mediated connexin-43 remodeling and sudden cardiac death. , 2011, Journal of the American College of Cardiology.

[6]  G. Fishman,et al.  Phosphatase-Resistant Gap Junctions Inhibit Pathological Remodeling and Prevent Arrhythmias , 2011, Circulation research.

[7]  R. Gourdie,et al.  Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1 , 2011, Molecular biology of the cell.

[8]  R. Gourdie,et al.  A Peptide Mimetic of the Connexin43 Carboxyl Terminus Reduces Gap Junction Remodeling and Induced Arrhythmia Following Ventricular Injury , 2011, Circulation research.

[9]  J. Baselga,et al.  Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors , 2010, Clinical Cancer Research.

[10]  M. Delmar,et al.  Cx43 CT domain influences infarct size and susceptibility to ventricular tachyarrhythmias in acute myocardial infarction. , 2009, Cardiovascular research.

[11]  Kenichi Yoshida,et al.  Ischemia enhances translocation of connexin43 and gap junction intercellular communication, thereby propagating contraction band necrosis after reperfusion. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[12]  Fabien Kieken,et al.  Structural and Molecular Mechanisms of Gap Junction Remodeling in Epicardial Border Zone Myocytes following Myocardial Infarction , 2009, Circulation research.

[13]  D. Hedley,et al.  Activation of Src and Src‐associated signaling pathways in relation to hypoxia in human cancer xenograft models , 2009, International journal of cancer.

[14]  J. Gilleron,et al.  Molecular reorganization of Cx43, Zo-1 and Src complexes during the endocytosis of gap junction plaques in response to a non-genomic carcinogen , 2008, Journal of Cell Science.

[15]  D. Segretain,et al.  Acute internalization of gap junctions in vascular endothelial cells in response to inflammatory mediator‐induced G‐protein coupled receptor activation , 2008, FEBS letters.

[16]  Guy Salama,et al.  Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia , 2007, Nature.

[17]  F. Cordelières,et al.  A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.

[18]  Ping Chen,et al.  2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase in , 2006, Journal of medicinal chemistry.

[19]  L. Otterbein,et al.  N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. , 2006, Journal of medicinal chemistry.

[20]  P. Lampe,et al.  Analysis of Connexin43 phosphorylated at S325, S328 and S330 in normoxic and ischemic heart , 2006, Journal of Cell Science.

[21]  J. Trevino,et al.  SRC inhibitors as potential therapeutic agents for human cancers. , 2006, Mini reviews in medicinal chemistry.

[22]  F. Lee,et al.  Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. , 2006, The American journal of pathology.

[23]  R. Gourdie,et al.  Zonula occludens-1 alters connexin43 gap junction size and organization by influencing channel accretion. , 2005, Molecular biology of the cell.

[24]  D. Spray,et al.  Structural Changes in the Carboxyl Terminus of the Gap Junction Protein Connexin43 Indicates Signaling between Binding Domains for c-Src and Zonula Occludens-1* , 2004, Journal of Biological Chemistry.

[25]  P. Lampe,et al.  The effects of connexin phosphorylation on gap junctional communication. , 2004, The international journal of biochemistry & cell biology.

[26]  R. Brandes,et al.  Hydrogen Peroxide Triggers Nuclear Export of Telomerase Reverse Transcriptase via Src Kinase Family-Dependent Phosphorylation of Tyrosine 707 , 2003, Molecular and Cellular Biology.

[27]  J. Saffitz,et al.  Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. , 2003, Journal of the American College of Cardiology.

[28]  W. Stevenson,et al.  Catheter Ablation in Patients With Multiple and Unstable Ventricular Tachycardias After Myocardial Infarction: Short Ablation Lines Guided by Reentry Circuit Isthmuses and Sinus Rhythm Mapping , 2001, Circulation.

[29]  B. Giepmans,et al.  Interaction of c-Src with Gap Junction Protein Connexin-43 , 2001, The Journal of Biological Chemistry.

[30]  M. Hori,et al.  c-Src Regulates the Interaction between Connexin-43 and ZO-1 in Cardiac Myocytes* , 2001, The Journal of Biological Chemistry.

[31]  J E Saffitz,et al.  Dephosphorylation and Intracellular Redistribution of Ventricular Connexin43 During Electrical Uncoupling Induced by Ischemia , 2000, Circulation research.

[32]  F. Marchlinski,et al.  Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. , 2000, Circulation.

[33]  B. Giepmans,et al.  The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein , 1998, Current Biology.

[34]  K. Otsu,et al.  Direct Association of the Gap Junction Protein Connexin-43 with ZO-1 in Cardiac Myocytes* , 1998, The Journal of Biological Chemistry.

[35]  Y Rudy,et al.  Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. , 1997, Circulation research.

[36]  Y. Zou,et al.  Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. , 1997, The Journal of clinical investigation.

[37]  N S Peters,et al.  Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. , 1997, Circulation.

[38]  J. Hanke,et al.  Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor , 1996, The Journal of Biological Chemistry.

[39]  B L Langille,et al.  Cardiac malformation in neonatal mice lacking connexin43. , 1995, Science.

[40]  P. Poole‐Wilson,et al.  Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. , 1993, Circulation.

[41]  D. Goodenough,et al.  Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques , 1991, The Journal of cell biology.

[42]  J M de Bakker,et al.  Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. , 1988, Circulation.

[43]  H. Wellens,et al.  Further Observations on Ventricular Tachycardia As Studied by Electrical Stimulation of the Heart: Chronic Recurrent Ventricular Tachycardia and Ventricular Tachycardia During Acute Myocardial Infarction , 1974, Circulation.

[44]  H. Wellens,et al.  Further Observations on Ventricular Tachycardia As Studied by Electrical Stimulation of the Heart , 1974 .

[45]  Mark D. Huffman,et al.  Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[46]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[47]  Sheila M. Thomas,et al.  Cellular functions regulated by Src family kinases. , 1997, Annual review of cell and developmental biology.

[48]  P. Brugada,et al.  Medical treatment of ventricular tachycardia: considerations in the selection of patients for surgical treatment. , 1982, The American journal of cardiology.